1. Andreasen NC, Carpenter WT Jr, Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry. 2005; 162:441–449.
2. Harrison G, Croudace T, Mason P, Glazebrook C, Medley I. Predicting the long-term outcome of schizophrenia. Psychol Med. 1996; 26:697–705.
3. Siegel SJ, Irani F, Brensinger CM, Kohler CG, Bilker WB, Ragland JD, et al. Prognostic variables at intake and long-term level of function in schizophrenia. Am J Psychiatry. 2006; 163:433–441.
4. Carpenter WT, Bartko JJ, Strauss JS, Hawk AB. Signs and symptoms as predictors of outcome: a report from the international pilot study of schizophrenia. Am J Psychiatry. 1978; 135:940–944.
5. Hawk AB, Carpenter WT Jr, Strauss JS. Diagnostic criteria and five-year outcome in schizophrenia. A report from the international pilot study of schizophrenia. Arch Gen Psychiatry. 1975; 32:343–347.
6. Tsuang MT, Woolson RF, Fleming JA. Long-term outcome of major psychoses. I. Schizophrenia and affective disorders compared with psychiatrically symptom-free surgical conditions. Arch Gen Psychiatry. 1979; 36:1295–1301.
7. Lauronen E, Miettunen J, Veijola J, Karhu M, Jones PB, Isohanni M. Outcome and its predictors in schizophrenia within the Northern Finland 1966 Birth Cohort. Eur Psychiatry. 2007; 22:129–136.
8. Bachmann S, Bottmer C, Schroder J. One-year outcome and its prediction in first-episode schizophrenia--a naturalistic study. Psychopathology. 2008; 41:115–123.
9. Bellack AS. Scientific and consumer models of recovery in schizophrenia: concordance, contrasts, and implications. Schizophr Bull. 2006; 32:432–442.
10. Mead S, Copeland ME. What recovery means to us: consumers’ perspectives. Community Ment Health J. 2000; 36:315–328.
11. Deegan PE. Recovery as a self-directed process of healing and transformation. Occup Ther Ment Health. 2002; 17:5–21.
12. Anthony WA. Recovery from mental illness: the guiding vision of the mental health service system in the 1990s. Psychosoc Rehabil J. 1993; 16:11–23.
13. Schrank B, Slade M. Recovery in psychiatry. Psychiatr Bull. 2007; 31:321–325.
14. Slade M, Amering M, Oades L. Recovery: an international perspective. Epidemiol Psichiatr Soc. 2008; 17:128–137.
15. Lysaker PH, Roe D, Buck KD. Recovery and wellness amidst schizophrenia: definitions, evidence, and the implications for clinical practice. J Am Psychiatr Nurses Assoc. 2010; 16:36–42.
16. Leendertse JCP, Wierdsma AI, van den Berg D, Ruissen AM, Slade M, Castelein S, et al. Personal recovery in people with a psychotic disorder: a systematic review and meta-analysis of associated factors. Front Psychiatry. 2021; 12:622628.
17. Lee JM, Kim CK. [Opinions on the recovery of outpatients with schizophrenia and their wills to recover]. Korean J Schizophr Res. 2021; 24:17–25. Korean.
18. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5). 5th ed. Arlington: American Psychiatric Association;2013.
19. Corrigan PW, Salzer M, Ralph RO, Sangster Y, Keck L. Examining the factor structure of the recovery assessment scale. Schizophr Bull. 2004; 30:1035–1041.
20. Lim KM, Shin ES, Shim SH, Jeong YJ. [Reliability and validity of the Korean version of the recovery assessment scale(RAS) for psychiatric patients]. J Korea Contents Assoc. 2014; 14:628–638. Korean.
21. Overall JE, Gorham DR. The brief psychiatric rating scale (BPRS): recent developments in ascertainment and scaling. Psychopharmacol Bull. 1988; 24:97–99.
22. Overall JE, Klett CJ. Applied multivariate analysis. New York: McGraw-Hill;1972.
23. Eisen SV, Dill DL, Grob MC. Reliability and validity of a brief patientreport instrument for psychiatric outcome evaluation. Hosp Community Psychiatry. 1994; 45:242–247.
24. Bae A, Hong CH, Shin J. [Validation study of the behavior and symptom identification scale(BASIS-32)]. Kor J Clin Psychol. 2011; 30:929–941. Korean.
25. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992; 30:473–483.
26. Koh SB, Chang SJ, Kang MG, Cha BS, Park JK. [Reliability and validity on measurement instrument for health status assessment in occupational workers]. J Prev Med Public Health. 1997; 30:251–266. Korean.
27. Kavanagh DJ, O’Halloran P, Manicavasagar V, Clark D, Piatkowska O, Tennant C, et al. The family attitude scale: reliability and validity of a new scale for measuring the emotional climate of families. Psychiatry Res. 1997; 70:185–195.
28. Dahlem NW, Zimet GD, Walker RR. The multidimensional scale of perceived social support: a confirmation study. J Clin Psychol. 1991; 47:756–761.
29. Hogan TP, Awad AG, Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med. 1983; 13:177–183.
30. Marks KA, Fastenau PS, Lysaker PH, Bond GR. Self-appraisal of illness questionnaire (SAIQ): relationship to researcher-rated insight and neuropsychological function in schizophrenia. Schizophr Res. 2000; 45:203–211.
31. Rosenberg M. Society and the adolescent self-image. Princeton: Princeton University Press;1965. p. 125–136.
32. Kim S, Lee EH, Hwang ST, Hong SH, Lee K, Kim JH. [Reliability and validity of the Korean version of the Beck hopelessness scale]. J Korean Neuropsychiatr Assoc. 2015; 54:84–90. Korean.
33. Chon HG, Kim CK. [The reliability and validity of the Korean version of psychiatric patients’ experience of stigma in the patients with schizophrenia]. Korean J Schizophr Res. 2010; 13:34–41. Korean.
34. Taylor DM, Barnes TRE, Young AH. The Maudsley prescribing guidelines in psychiatry. 13th ed. London: Wiley-Blackwell;2018. p. 15.
35. Van Eck RM, Burger TJ, Vellinga A, Schirmbeck F, de Haan L. The relationship between clinical and personal recovery in patients with schizophrenia spectrum disorders: a systematic review and metaanalysis. Schizophr Bull. 2018; 44:631–642.
36. Leamy M, Bird V, Le Boutillier C, Williams J, Slade M. Conceptual framework for personal recovery in mental health: systematic review and narrative synthesis. Br J Psychiatry. 2011; 199:445–452.
37. Kim JG, Ahn JY, Kim CK. [Factors affecting the empowerment experienced by outpatients with schizophrenia]. Korean J Schizophr Res. 2018; 21:59–66. Korean.
38. Misdrahi D, Denard S, Swendsen J, Jaussent I, Courtet P. Depression in schizophrenia: the influence of the different dimensions of insight. Psychiatry Res. 2014; 216:12–16.
39. Schaub D, Brüne M, Bierhoff HW, Juckel G. Comparison of self- and clinician’s ratings of personal and social performance in patients with schizophrenia: the role of insight. Psychopathology. 2012; 45:109–116.
40. Kurtz MM, Olfson RH, Rose J. Self-efficacy and functional status in schizophrenia: relationship to insight, cognition and negative symptoms. Schizophr Res. 2013; 145:69–74.
41. Ho WW, Chiu MY, Lo WT, Yiu MG. Recovery components as determinants of the health-related quality of life among patients with schizophrenia: structural equation modelling analysis. Aust N Z J Psychiatry. 2010; 44:71–84.
42. Yanos PT, Rosenfield S, Horwitz AV. Negative and supportive social interactions and quality of life among persons diagnosed with severe mental illness. Community Ment Health J. 2001; 37:405–419.